KA/EN
Register
Medicines reference
Search
Search
Active substance

Tetracycline

Favourites

Tetracycline. Registered in Georgia: 1 human medicine. Forms: ointment.

Dose and use

Doses

We have no dose with a cited source for this substance yet.

Before use

Safety information

No sourced safety entry is currently shown. This does not mean the substance is risk-free.

Latin name
Tetracycline
Georgian name
ტეტრაციკლინი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
1 of 1 forms
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration1

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

Tetracycline 10 mg/g (1%), Ointment

eye ointment, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Potential topical treatment of a confirmed susceptible superficial bacterial ocular infection with the unidentified tetracycline 1% human ointment represented by this aggregated catalogue row
Not rateable
No numerical score assigned
vetman assessment

Tetracycline 10 mg/g (1%)

eye ointment, human medicine
Assessed clinical scopeDog · Potential topical treatment of a confirmed susceptible superficial bacterial ocular infection with the unidentified tetracycline 1% human ointment represented by this aggregated catalogue row · Into the eye
Care settingVeterinarian-directed treatment only after complete ocular examination, pathogen/role assessment and exact tube, manufacturer, pack and current label identification
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, human · № რ-037621, რ-038495 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned because this catalogue row is not one exact finished product. It merges at least Arpimed 3 g and Ukrfarmexport/Medipharco 5 g authorisations while omitting manufacturer, pack and product-specific label. Arpimed has an official human label, but an equivalent primary full label was not located for the second product; neither has exact dog/cat outcome, safety or dose evidence. Current chlortetracycline and oxytetracycline veterinary ointments support class plausibility only and cannot establish tetracycline-product equivalence or a transferable regimen.

Topical tetracycline-class therapy can have a legitimate veterinary role, especially against selected Chlamydia/Mycoplasma targets, but this aggregated human-product row cannot receive one defensible score or dose. Split it into exact 3 g and 5 g products, map each current label and then assess each independently.

Important safety and use flags

  • This is an aggregate, not an exact product: it combines Arpimed 3 g and Ukrfarmexport/Medipharco 5 g under one generic row. Confirm the tube, manufacturer, authorisation number, pack and current label before any product-specific decision.
  • No dog/cat dose is published for this aggregate. Do not copy the Arpimed human 0.5-1 cm ribbon or the veterinary Ophtocycline/Terramycin schedule; those are different exact products and the veterinary comparators use chlortetracycline or oxytetracycline.
  • Use only for a coherent susceptible bacterial target after complete ocular examination and fluorescein assessment. Viral, fungal, sterile, deep/melting or intraocular disease requires different diagnostics and treatment; an undifferentiated red eye is not an antibiotic indication.
  • For feline Chlamydia felis, topical treatment alone may improve signs but does not reliably eradicate systemic infection. Follow current PCR-informed systemic doxycycline guidance and treat in-contact cats when indicated rather than relying on ointment alone.
  • Tetracyclines are bacteriostatic and susceptibility is organism- and region-dependent. Obtain cytology/culture for deep, recurrent, previously treated or poorly responding disease and reassess promptly when the expected response is absent.
  • Stop and reassess for lid swelling, erythema, pruritus, increasing pain or another hypersensitivity reaction. Ophthalmic antibiotics are not predictably benign in every cat; avoid unnecessary prophylactic exposure.
  • Avoid tube-tip contact with the eye, lashes, skin or fingers and do not share a tube between patients. Ointment can transiently blur vision and the exact post-opening period and storage rule must come from the identified product label.
  • Pregnancy, lactation, juvenile-animal and prolonged-use safety cannot be inferred across the two hidden products or from another tetracycline. Perform an exact-label benefit-risk review before use in these populations.
  • A future catalogue repair should split the 3 g and 5 g products and preserve their separate authorisation, manufacturer, excipient, pack and label evidence. Do not convert this identity defect into a low numerical score; it is a not-rateable data boundary.
Assessment sources
  1. Tetracycline ointment aggregate audit2026
  2. Arpimed tetracycline ointment label2026
  3. Ophtocycline veterinary SPC2025
  4. Ophtocycline EU authorisation2026
  5. Ophtocycline public assessment2026
  6. Terramycin veterinary comparator2026
  7. Merck ophthalmic antimicrobials2025
  8. Canine oxytetracycline ointment PK2020
  9. Ophthalmic antimicrobial stewardship2026
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Potential topical treatment of a confirmed susceptible superficial bacterial ocular infection with the unidentified tetracycline 1% human ointment represented by this aggregated catalogue row
Not rateable
No numerical score assigned
vetman assessment

Tetracycline 10 mg/g (1%)

eye ointment, human medicine
Assessed clinical scopeCat · Potential topical treatment of a confirmed susceptible superficial bacterial ocular infection with the unidentified tetracycline 1% human ointment represented by this aggregated catalogue row · Into the eye
Care settingVeterinarian-directed treatment only after complete ocular examination, pathogen/role assessment and exact tube, manufacturer, pack and current label identification
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, human · № რ-037621, რ-038495 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned because this catalogue row is not one exact finished product. It merges at least Arpimed 3 g and Ukrfarmexport/Medipharco 5 g authorisations while omitting manufacturer, pack and product-specific label. Arpimed has an official human label, but an equivalent primary full label was not located for the second product; neither has exact dog/cat outcome, safety or dose evidence. Current chlortetracycline and oxytetracycline veterinary ointments support class plausibility only and cannot establish tetracycline-product equivalence or a transferable regimen.

Topical tetracycline-class therapy can have a legitimate veterinary role, especially against selected Chlamydia/Mycoplasma targets, but this aggregated human-product row cannot receive one defensible score or dose. Split it into exact 3 g and 5 g products, map each current label and then assess each independently.

Important safety and use flags

  • This is an aggregate, not an exact product: it combines Arpimed 3 g and Ukrfarmexport/Medipharco 5 g under one generic row. Confirm the tube, manufacturer, authorisation number, pack and current label before any product-specific decision.
  • No dog/cat dose is published for this aggregate. Do not copy the Arpimed human 0.5-1 cm ribbon or the veterinary Ophtocycline/Terramycin schedule; those are different exact products and the veterinary comparators use chlortetracycline or oxytetracycline.
  • Use only for a coherent susceptible bacterial target after complete ocular examination and fluorescein assessment. Viral, fungal, sterile, deep/melting or intraocular disease requires different diagnostics and treatment; an undifferentiated red eye is not an antibiotic indication.
  • For feline Chlamydia felis, topical treatment alone may improve signs but does not reliably eradicate systemic infection. Follow current PCR-informed systemic doxycycline guidance and treat in-contact cats when indicated rather than relying on ointment alone.
  • Tetracyclines are bacteriostatic and susceptibility is organism- and region-dependent. Obtain cytology/culture for deep, recurrent, previously treated or poorly responding disease and reassess promptly when the expected response is absent.
  • Stop and reassess for lid swelling, erythema, pruritus, increasing pain or another hypersensitivity reaction. Ophthalmic antibiotics are not predictably benign in every cat; avoid unnecessary prophylactic exposure.
  • Avoid tube-tip contact with the eye, lashes, skin or fingers and do not share a tube between patients. Ointment can transiently blur vision and the exact post-opening period and storage rule must come from the identified product label.
  • Pregnancy, lactation, juvenile-animal and prolonged-use safety cannot be inferred across the two hidden products or from another tetracycline. Perform an exact-label benefit-risk review before use in these populations.
  • A future catalogue repair should split the 3 g and 5 g products and preserve their separate authorisation, manufacturer, excipient, pack and label evidence. Do not convert this identity defect into a low numerical score; it is a not-rateable data boundary.
Assessment sources
  1. Tetracycline ointment aggregate audit2026
  2. Arpimed tetracycline ointment label2026
  3. Ophtocycline veterinary SPC2025
  4. Ophtocycline EU authorisation2026
  5. Ophtocycline public assessment2026
  6. Terramycin veterinary comparator2026
  7. Merck ophthalmic antimicrobials2025
  8. ABCD Chlamydia felis guideline2026
  9. Feline conjunctivitis diagnostic review2021
  10. Feline ophthalmic antibiotic anaphylaxis2011
  11. Ophthalmic antimicrobial stewardship2026
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Tetracycline10 mg/g
Formulation Type
Ointment
Administration route
Into the eye
Manufacturer
-
Product
generic presentation, not registered in Georgia under a trade name
Registration
Georgia Yes, human
In force until 30 Jun 2028
Human (Ministry of Health, RAMA)
In the register: ტეტრაციკლინი 1% თვალის მალამო
№ რ-037621, რ-038495
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified This catalogue row aggregates at least two current Georgian products (Arpimed 3 g and Ukrfarmexport/Medipharco 5 g) and does not identify which tube is being used. No product-specific dog/cat dose is published. Do not transfer the Arpimed human ribbon or the veterinary chlortetracycline/oxytetracycline comparators; identify the exact pack and label first.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗